siRNA is a part of an innovative strategy to disrupt the activity of cancer-related genes that has broad applications to other diseases.
In the May 1 issue of Cancer Research, the scientists reported that a multistage nanovector system for the delivery of siRNA significantly lengthened the therapeutic effects of the treatment in two independent mouse models of advanced ovarian cancer.
The researchers reported that a single intravenous dose of siRNA targeting the EphA2 oncoprotein provided the same tumor shrinkage for three weeks as that now achieved by six doses over the same period.
“The multistage delivery system is revolutionary in that it allows the therapeutic payloads to cross the biological barriers in the body and reach their target. It further helps release agents over long periods of time directly into the bloodstream, which is unprecedented,” said Mauro Ferrari, Ph.D., chairman of the Department of NanoMedicine and Biomedical Engineering at The University of Texas Medical School at Houston, which is part of UTHealth. “We are very excited about the results of this paper, since it provides the first validation of the therapeutic advantages of the multistage delivery system in animal models of cancer.”
The multistage nanovector system is composed of nanoporous silicon carrier particles that are about 100 times smaller than a strand of hair, which can be loaded with tiny bubbles of fat called nanoliposomes containing siRNA. The system provides for the release of the nanoliposomes and their contents.
“This is an exciting development because RNA interference has worked well in an animal model but has such a short half-life that it requires frequent delivery. A three-week dosing period is much closer to the sustained dosing needed to properly test this therapy in clinical trials,” said Anil Sood, M.D., professor in M.D. Anderson’s Departments of Gynecological Oncology and Cancer Biology.
The multistage nanovector system was developed in Ferrari’s laboratory and the liposomal siRNA was developed at M. D. Anderson.
“We have provided the first in vivo therapeutic validation of a novel, multistage siRNA delivery system for sustained gene silencing with broad applicability to pathologies,” wrote Takemi Tanaka, Ph.D., a co-first author and a research assistant professor of nanomedicine and biomedical engineering at the UT Medical School at Houston, and the other investigators in the paper..
Gabriel Lopez-Berestein, M.D., professor of experimental therapeutics at M. D. Anderson, Sood, co-director of M. D. Anderson’s Center for RNA Interference and Non-Coding RNA, and Ferrari are the senior authors.
“EphA2 is an important target because it’s overexpressed in 70 percent of ovarian cancers and is strongly associated with poor survival and a higher likelihood of advanced or metastatic disease,” said Lopez-Berestein. “It’s also overexpressed in melanoma, breast and lung cancers with the same poor prospects for patients.”
The protein is not present in normal tissue and cannot be attacked using more traditional drug approaches.
Study contributors from UTHealth include: René Nieves-Alicea, Ph.D.; Aman Preet Singh Mann, Xuewu Liu, Ph.D.; Rohan Bhavane, Jianhua Gu, Jean Fakhoury and Biana Godin, Ph.D.
M. D. Anderson contributors include: Lingegowda S. Mangala, Ph.D., co-first author; Edna Mora, M.D.; Hee-Dong Han, Pablo E. Vivas-Mejia, Ph.D.; Mian M.K. Shahzad, Chunhua Lu, Koji Matsuo, Rebecca Stone, M.D.; and Alpa Nick, M.D.
Ciro Chiappini, a graduate research assistant at The University of Texas at Austin, also contributed to the study.
The study, which is titled “Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles,” received support from the Department of Defense, the State of Texas Emerging Technology Fund, National Aeronautics and Space Administration, the Ovarian Cancer Research Fund Program Project Development Grant, The University of Texas M.D. Anderson Cancer Center Ovarian Cancer Specialized Program of Research Excellence, the National Institutes of Health, the Zarrow Foundation, the Betty Ann Asche Murray Distinguished Professorship, the Baylor WRHR Grant and the GCF Molly-Cade Ovarian Cancer Research Grant and the Alliance for NanoHealth.
Ferrari serves as a professor of experimental therapeutics at the M. D. Anderson Cancer Center, adjunct professor of bioengineering at Rice University, adjunct professor of biochemistry and molecular biology at The University of Texas Medical Branch at Galveston, adjunct professor of engineering at the University of Houston, and president of the Alliance for NanoHealth.Rob Cahill
Robert Cahill | EurekAlert!
New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg
Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
24.02.2017 | Life Sciences
24.02.2017 | Life Sciences
24.02.2017 | Trade Fair News